Clinical Trial Update: Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial evaluated oral Gastrografin for meconium evacuation in very low birth weight infants. The study status shows completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meconium Ileus

Drugs mentioned

• Gastrografin (diatrizoate meglumine and diatrizoate sodium)

Snippet

Sponsor: Nadja Haiden,MD | Conditions: Meconium Ileus, Very Low Birth Weight Infant | Phase 4 | Status: COMPLETED | Results posted: 2014-07-18